Status and phase
Conditions
Treatments
About
This study will evaluate the effectiveness and safety of denosumab in treating women with Postmenopausal Osteoporosis.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
7,808 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal